Related Experiment Video
Updated: Jan 18, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
Investigating the interaction mechanism of five flavonoids and PD-L1 based on multi-spectroscopy and molecular
Yijie Cai1, Yijun Tu2, Hong Cheng2
1Department of Pharmacy, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, China; Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, and Wuhan University School of Pharmaceutical Sciences, Wuhan, 430071, China.
None:
PD-L1 is an important protein overexpressed in various types of cancer. Flavonoids as common antioxidants have extensive bioactivities. In this study, the interaction mechanism and the structure-activity relationship between the five flavonoids and extracellular domain of PD-L1 (PD-L1-ECD) were investigated using integrated spectroscopy and computational simulation. Fluorescence spectra showed that the quenching mechanisms of the interaction between the five flavonoids and PD-L1-ECD were static quenching. Circular dichroism (CD) spectra showed that the five flavonoids caused conformational changes of PD-L1-ECD. Computational simulation data showed the different binding patterns between five flavonoids and PD-L1-ECD. The binding affinity of the five flavonoids which affected by hydrogenation of C2=C3 bond and the substitution of C3 decreased in the following order: luteolin > kaempferol > spinacetin > axillarin > hesperetin. This study suggested that five flavonoids could bind to the PD-L1-ECD, thereby establishing a foundation for developing these compounds as small-molecule PD-L1 inhibitors. Subsequent structure-activity relationship was studied based on distinct binding modes and binding affinity, and it will contribute to structural modifications to optimize therapeutic potency.
More Related Videos
05:30Author Spotlight: Streamlining PCR Methods for Enhanced Accessibility and Efficiency
Published on: March 1, 2024
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023